Drug Profile
Research programme: kinase inhibitors - OncoTherapy Science/Carna Biosciences/CrystalGenomics
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Carna Biosciences; CrystalGenomics; OncoTherapy Science
- Class Small molecules
- Mechanism of Action Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer